request a demo SIGN IN
request a demo
let's connect!
i1 i2 i3
Use Case
About us

Bridge Legal August Tort Roundup

on September 6, 2022

Our monthly roundup of the latest news and topics impacting your practice.

We know that providing your clients with the latest developments in tort cases is essential. That’s why we compile the highlights from our Tort Report newsletter so you can keep track of the latest news and topics impacting your practice.

Interested in receiving weekly tort updates? Subscribe to our weekly Tort Report here.

Roundup trials kick off while Paraquat are planned for early 2023.

President Joe Biden has signed the Camp Lejeune Justice Act into law. Individuals who were exposed to tainted water at Camp Lejeune will now be able to seek compensation from the federal government following the passage of the Camp Lejeune Justice Act by the U.S. Senate.

Read our latest blog post for a lookback on the Camp Lejeune crisis.

Roundup trials kick off while Paraquat are planned for early 2023.

The first local trial is underway in a lawsuit over the weed killer product Roundup. The lawsuit claims Bayer-owned Monsanto’s popular herbicide causes cancer. Three plaintiffs in their 60s and 70s claim long-time exposure to Roundup—specifically the chemical glyphosate—gave them lymphoma and that Monsanto neglected to warn the public of its dangers. Monsanto claims Roundup does not cause cancer.

The U.S. District Judge presiding over all federal Paraquat lawsuits indicates that the parties must complete depositions and limited discovery in another 20 cases involving Parkinson’s disease diagnosed among former users of the pesticide, while a prior group of bellwether claims are being prepared for early trial dates next year.

Plaintiff in first Zantac lawsuit set for trial drops case

The plaintiff in the first lawsuit over the heartburn drug Zantac scheduled to go to trial has agreed to drop his case, according to his attorney and drugmakers named as defendants.

Sanofi, GSK Plc and Haleon Plc have lost a combined $40 billion in market value since Tuesday’s close amid mounting concerns about litigation around the recalled heartburn drug Zantac.

New hernia mesh failure claims surface.

LifeCell Corporation faces a hernia mesh lawsuit brought by a South Carolina woman, who was left with painful and life-long injuries after a Strattice tissue matrix used during a hernia repair failed, resulting in the need for revision surgery only a year later.

Becton Dickinson & Co. units allegedly used plastic in its hernia mesh kits that its supplier deemed unfit for that type of use, according to newly unsealed court filings made public as part of a trial.

Interested in staying up-to-date on the latest in tort developments and upcoming webcasts? Subscribe to our Tort Report newsletter.

Ready to give us a try?

We help legal professionals streamline their processes, enhance efficiency, and drive better results with a comprehensive suite of cutting-edge tools and services tailored to their unique needs.

request a demo